OncLive
OncLive TV provides short, focused interviews with key oncology thought leaders. This unique platform allows oncology professionals to learn about important developments directly from their peers.- 2:37
- 14 сағат бұрын
Dr Necchi on the Efficacy and Safety of TAR-200 Plus Cetrelimab in MIBC
- 1:16
- 14 сағат бұрын
Dr Xu on the Preliminary Efficacy of SHR-A1904 in Gastric/GEJ Cancer
- 4:09
- 16 сағат бұрын
Past, Present, and Future of Precision Cancer Medicine: Episode 1
- 1:36
- 14 күн бұрын
Dr Girard on Nivolumab Plus Relatlimab and Chemotherapy in Stage IV or Recurrent NSCLC
- 0:59
- 14 күн бұрын
Dr Wilky on a Study of Botensilimab Plus Balstilimab in Refractory Metastatic Sarcoma
- 2:59
- 14 күн бұрын
Dr Chalasani on the Potential Utility of Eftilagimod Alpha in HER2-/HER2-Low Breast Cancer
- 1:55
- 14 күн бұрын
Dr Danilov on Ongoing MCL Clinical Trials
- 1:34
- 14 күн бұрын
ASCO 2024 Applications in Gynecologic Oncology: Episode 3
- 2:18
- 14 күн бұрын
Dr Heymach on Updated AEGEAN Data in Resectable NSCLC
- 3:13
- 14 күн бұрын
Dr Rosca on Key Challenges in Genetic Testing for Lung Cancer
- 0:59
- 21 күн бұрын
Dr Nowakowski on the Current Treatment Landscape for DLBCL
- 4:40
- 21 күн бұрын
Dr Ornstein on the Use of IO/TKI Doublets in Non-ccRCC
- 1:05
- 21 күн бұрын
Dr Seymour on the Role of Mutational Profiling in CLL
- 2:02
- 21 күн бұрын
ASCO 2024 Applications in Gynecologic Oncology: Episode 2
- 1:12
- 21 күн бұрын
Dr Powell on the FDA Approval of Dostarlimab Plus Chemo in Advanced/Recurrent Endometrial Cancer
- 1:24
- 21 күн бұрын
Dr Nagpal on the FDA Approval of Vorasidenib for Grade 2 Astrocytoma or Oligodendroglioma
- 1:53
- 21 күн бұрын
Пікірлер